PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.74 -1.17 (-5.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023)

PROCEPT BioRobotics (PRCT) posted quarterly Non-Current Deffered Revenue of $517000.0 for Q3 2023, up 44.82% quarter-over-quarter from $357000.0 in Q2 2023.

PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Non-Current Deffered Revenue for 1 consecutive years, with $517000.0 the latest figure, recorded in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 539.34 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 PROCEPT BioRobotics 1.19 Bn 911.91 Mn 62.38 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 517,000.00
Jun 30, 2023 357,000.00